Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William C Knowler

Showing results (271-280 of 323) with videos related to

Pageof 33
Sort By:
The American Journal of Clinical Nutrition|July 17, 2025
The 2018 World Cancer Research Fund/American Institute for Cancer Research Score and Cancer Risk: results from the diabetes prevention program outcomes studyAshley H Tjaden, Audrey A Goldbaum, Sharon L Edelstein, et al.
Diabetes|August 7, 2015
ABCC8 R1420H Loss-of-Function Variant in a Southwest American Indian Community: Association With Increased Birth Weight and Doubled Risk of Type 2 DiabetesLeslie J Baier, Yunhua Li Muller, Maria Sara Remedi, et al.
The Lancet. Diabetes & Endocrinology|May 1, 2025
Long-term effects and effect heterogeneity of lifestyle and metformin interventions on type 2 diabetes incidence over 21 years in the US Diabetes Prevention Program randomised clinical trialWilliam C Knowler, Lindsay Doherty, Sharon L Edelstein, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 5, 2015
Urinary monocyte chemoattractant protein-1 and hepcidin and early diabetic nephropathy lesions in type 1 diabetes mellitusGudeta D Fufaa, E Jennifer Weil, Robert G Nelson, et al.
Diabetes|October 23, 2019
Interaction Between Type 2 Diabetes Prevention Strategies and Genetic Determinants of Coronary Artery Disease on Cardiometabolic Risk FactorsJordi Merino, Kathleen A Jablonski, Josep M Mercader, et al.
The Journal of Clinical Endocrinology and Metabolism|October 26, 2018
Genetic Ancestry Markers and Difference in A1c Between African American and White in the Diabetes Prevention ProgramMarie-France Hivert, Costas A Christophi, Kathleen A Jablonski, et al.
Psychosomatic Medicine|August 24, 2016
Replication of the Association of BDNF and MC4R Variants With Dietary Intake in the Diabetes Prevention ProgramJeanne M McCaffery, Kathleen A Jablonski, Paul W Franks, et al.
The Journal of Clinical Endocrinology and Metabolism|April 29, 2017
Variation in Maturity-Onset Diabetes of the Young Genes Influence Response to Interventions for Diabetes PreventionLiana K Billings, Kathleen A Jablonski, A Sofia Warner, et al.
Diabetes|October 5, 2019
Metabolite Profiles of Incident Diabetes and Heterogeneity of Treatment Effect in the Diabetes Prevention ProgramZsu-Zsu Chen, Jinxi Liu, Jordan Morningstar, et al.
Diabetes|October 9, 2013
A genome-wide association study in American Indians implicates DNER as a susceptibility locus for type 2 diabetesRobert L Hanson, Yunhua L Muller, Sayuko Kobes, et al.
Pageof 33

Showing results (271-280 of 323) with videos related to

Sort By:
Pageof 33
The American Journal of Clinical Nutrition|July 17, 2025
The 2018 World Cancer Research Fund/American Institute for Cancer Research Score and Cancer Risk: results from the diabetes prevention program outcomes studyAshley H Tjaden, Audrey A Goldbaum, Sharon L Edelstein, et al.
Diabetes|August 7, 2015
ABCC8 R1420H Loss-of-Function Variant in a Southwest American Indian Community: Association With Increased Birth Weight and Doubled Risk of Type 2 DiabetesLeslie J Baier, Yunhua Li Muller, Maria Sara Remedi, et al.
The Lancet. Diabetes & Endocrinology|May 1, 2025
Long-term effects and effect heterogeneity of lifestyle and metformin interventions on type 2 diabetes incidence over 21 years in the US Diabetes Prevention Program randomised clinical trialWilliam C Knowler, Lindsay Doherty, Sharon L Edelstein, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 5, 2015
Urinary monocyte chemoattractant protein-1 and hepcidin and early diabetic nephropathy lesions in type 1 diabetes mellitusGudeta D Fufaa, E Jennifer Weil, Robert G Nelson, et al.
Diabetes|October 23, 2019
Interaction Between Type 2 Diabetes Prevention Strategies and Genetic Determinants of Coronary Artery Disease on Cardiometabolic Risk FactorsJordi Merino, Kathleen A Jablonski, Josep M Mercader, et al.
The Journal of Clinical Endocrinology and Metabolism|October 26, 2018
Genetic Ancestry Markers and Difference in A1c Between African American and White in the Diabetes Prevention ProgramMarie-France Hivert, Costas A Christophi, Kathleen A Jablonski, et al.
Psychosomatic Medicine|August 24, 2016
Replication of the Association of BDNF and MC4R Variants With Dietary Intake in the Diabetes Prevention ProgramJeanne M McCaffery, Kathleen A Jablonski, Paul W Franks, et al.
The Journal of Clinical Endocrinology and Metabolism|April 29, 2017
Variation in Maturity-Onset Diabetes of the Young Genes Influence Response to Interventions for Diabetes PreventionLiana K Billings, Kathleen A Jablonski, A Sofia Warner, et al.
Diabetes|October 5, 2019
Metabolite Profiles of Incident Diabetes and Heterogeneity of Treatment Effect in the Diabetes Prevention ProgramZsu-Zsu Chen, Jinxi Liu, Jordan Morningstar, et al.
Diabetes|October 9, 2013
A genome-wide association study in American Indians implicates DNER as a susceptibility locus for type 2 diabetesRobert L Hanson, Yunhua L Muller, Sayuko Kobes, et al.
Pageof 33